NDC Code(s) : 43547-435-06
Packager : Solco Healthcare LLC
Category : HUMAN PRESCRIPTION DRUG LABEL
DEA Schedule : none
Marketing Status : New Drug Application
INGREDIENTS AND APPEARANCE
Clonidine HydrochlorideClonidine Hydrochloride TABLET, EXTENDED RELEASE | ||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
LABELER - Solco Healthcare LLC(828343017) |
PRINCIPAL DISPLAY PANEL
Container Label - 0.1 mg - 60 tablets
NDC 43547-435-06 Rx only
Clonidine Hydrochloride Extended-Release Tablets
0.1 mg per tablet
60 Tablets
Each extended-release tablet contains: 0.1 mg clonidine hydrochloride equivalent to 0.087 mg clonidine.
Usual Dosage: See package insert for full prescribing information.
Clonidine hydrochloride extended-release tablets must be swallowed whole and never crushed, cut or chewed.
Do not substitute clonidine hydrochloride extended-release tablets for other clonidine products.
Keep out of reach of children.
Store at 20° to 25°C(68° to 77°F); excursions permitted between 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature].
Manufactured by:
Xiamen LP Pharmaceutical Co., Ltd.
Xiamen, Fujian 361027, China
Distributed by:
Solco Healthcare US, LLC
Cranbury, NJ 08512, USA
Rev.: 12/2017
PK0029